If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
1,969.00    -21.00 (-1.06%)
Bid:
1,967.00
Ask:
1,969.00
Spread: 2.00 (0.102%)
Market Cap: £3.31b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Update on Catalyst Technologies sale

23 Feb 2026 07:00

RNS Number : 9927T
Johnson Matthey PLC
23 February 2026
 

23rd February 2026

 

Johnson Matthey Plc

(the Company)

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

Transaction update

On 22nd May 2025, Johnson Matthey Plc ("JM") and Honeywell International, Inc. ("Honeywell") announced an agreement to sell JM's Catalyst Technologies business ("CT") to Honeywell (the "Transaction").

JM and Honeywell have agreed to extend the long stop date for satisfaction of the closing conditions (the "Long Stop Date") from 21st February to 21st July 2026. In the event that the only remaining antitrust approval condition is not satisfied by the Long Stop Date, the Long Stop Date may be further extended to 21st August 2026, if certain conditions are met. JM and Honeywell expect to complete the Transaction by the end of August 2026.

In agreeing to extend the Long Stop Date, JM and Honeywell have also agreed to amend the financial terms of the Transaction to reflect CT's business performance during 2025/26, which includes the deferral of key sustainable solutions licensing projects and reduced profitability from the supply of catalysts due to the challenging market environment. Accordingly, JM has agreed to sell the CT business to Honeywell for an enterprise value of £1,325 million on a cash and debt-free basis.

Consequently, JM now expects to return c.£1,000 million of net sale proceeds to its shareholders following completion of the Transaction, comprising £800 million through a special dividend with share consolidation, and £200 million through an on-market share buyback programme.

JM continues to make good progress on the implementation of its new cash-focused business model and is on track to deliver 2025/26 performance in line with guidance. This includes group underlying operating profit growth at the higher end of a mid single digit percentage range¹, and positive free cash flow that is materially higher than last year².

The person responsible for the release of this announcement is Simon Price, General Counsel and Company Secretary of JM.

ENDS

 

Enquiries: 

Investor Relations

 

 

Louise Curran

Head of Investor Relations

+44 20 7269 8235

Media

Sinead Keller

Guy Bates 

Group External Relations Director

Kekst CNC

+44 20 7269 8218

+44 7581 056 415

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

 

Notes:

1.

Underlying operating profit is on a pro forma basis excluding CT and Value Businesses, and at constant precious metal prices and constant currency. 

2.

Free cash flow defined as net cash flow from operating activities (excluding disposal related costs) after net interest paid, net purchases of non-current assets and investments and the principal elements of lease payments, adjusted to reflect the classification of Catalyst Technologies as a discontinued operation. 2024/25: £64 million inflow.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURXLLLLQLLEBBF
Date   Source Headline
11th Jan 20227:00 amRNSTransaction in Own Shares
10th Jan 202212:16 pmRNSHolding(s) in Company
10th Jan 20227:00 amRNSTransaction in Own Shares
7th Jan 202212:06 pmRNSDirector/PDMR Shareholding
7th Jan 20227:00 amRNSTransaction in Own Shares
6th Jan 202211:39 amRNSDirector/PDMR Shareholding
6th Jan 20227:00 amRNSTransaction in Own Shares
5th Jan 20225:21 pmRNSDirector/PDMR Shareholding
5th Jan 20227:00 amRNSTransaction in Own Shares
4th Jan 202211:45 amRNSDirector/PDMR Shareholding
4th Jan 20229:40 amRNSTotal Voting Rights
4th Jan 20227:00 amRNSTransaction in Own Shares
31st Dec 20217:00 amRNSTransaction in Own Shares
30th Dec 20217:00 amRNSTransaction in Own Shares
29th Dec 20217:00 amRNSTransaction in Own Shares
24th Dec 20217:00 amRNSTransaction in Own Shares
23rd Dec 20219:30 amRNSDirector/PDMR Shareholding
23rd Dec 20217:00 amRNSTransaction in Own Shares
22nd Dec 20214:00 pmRNSDirector/PDMR Shareholding
22nd Dec 20217:00 amRNSTransaction in Own Shares - Replacement
21st Dec 20216:28 pmRNSTransaction in Own Shares
21st Dec 20214:15 pmRNSDirector/PDMR Shareholding
21st Dec 20211:47 pmRNSDirector/PDMR Shareholding
21st Dec 20217:00 amRNSShare buyback programme
20th Dec 20214:11 pmRNSDirector/PDMR Shareholding
17th Dec 20214:16 pmRNSHolding(s) in Company
17th Dec 20213:44 pmRNSDirector/PDMR Shareholding
17th Dec 20213:18 pmRNSDirector/PDMR Shareholding
17th Dec 20217:00 amRNSSale of Health
16th Dec 20212:20 pmRNSHolding(s) in Company
10th Dec 20214:40 pmRNSHolding(s) in Company
26th Nov 20215:15 pmRNSHolding(s) in Company
25th Nov 20214:30 pmRNSHolding(s) in Company
24th Nov 20217:00 amRNSSale of Advanced Glass Technologies
24th Nov 20217:00 amRNSJohnson Matthey half year results 30th Sept 2021
19th Nov 20213:30 pmRNSHolding(s) in Company
19th Nov 20212:02 pmRNSDirector/PDMR Shareholding
17th Nov 20219:47 amRNSHolding(s) in Company
11th Nov 20217:00 amRNSIntent to exit Battery Materials, trading update
11th Nov 20217:00 amRNSChief Executive Announcement
1st Nov 20218:30 amRNSJane Griffiths - External Directorship
22nd Oct 202110:13 amRNSDirector/PDMR Shareholding
12th Oct 202110:47 amRNSHolding(s) in Company
5th Oct 20218:00 amRNSJohn O'Higgins - External Directorship
28th Sep 202112:25 pmRNSHolding(s) in Company
20th Sep 20211:20 pmRNSHolding(s) in Company
16th Sep 202112:45 pmRNSDirector/PDMR Shareholding
25th Aug 20216:01 pmRNSHolding(s) in Company
20th Aug 20212:51 pmRNSDirector/PDMR Shareholding
18th Aug 20214:21 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.